SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-164037
Filing Date
2024-06-20
Accepted
2024-06-20 08:32:09
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d853461d424b5.htm 424B5 385359
2 GRAPHIC g853461g10m87.jpg GRAPHIC 61229
3 GRAPHIC g853461g16a86.jpg GRAPHIC 615388
4 GRAPHIC g853461g75l01.jpg GRAPHIC 52757
  Complete submission text file 0001193125-24-164037.txt   1387139
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-257990 | Film No.: 241054215
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)